PREVNAR 13 (Pneumococcal 13-valent Conjugate Vaccine)
In children 6 weeks through 5 years of age (prior to the 6 th birthday). Prevnar 13 is indicated for: active immunization for the prevention of invasive disease caused by…
Wyeth Pharmaceutical Division of Wyeth Holdings LLC Products: Vaccine Labels and Information Section
Prevnar 20 (Pneumococcal 20-valent Conjugate Vaccine)
Prevnar 20 is a vaccine indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A,…
Trumenba (Meningococcal Group B Vaccine)
Trumenba is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Trumenba is approved for use in individuals 10 through 25 years of…